Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Profit After Tax: 2009-2024

Historic Profit After Tax for Fresenius Medical Care AG (FMS) over the last 16 years, with Dec 2024 value amounting to $791.7 million.

  • Fresenius Medical Care AG's Profit After Tax rose 32.00% to $382.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 6.54%. This contributed to the annual value of $791.7 million for FY2024, which is 0.08% down from last year.
  • Fresenius Medical Care AG's Profit After Tax amounted to $791.7 million in FY2024, which was down 0.08% from $792.3 million recorded in FY2023.
  • In the past 5 years, Fresenius Medical Care AG's Profit After Tax registered a high of $1.6 billion during FY2020, and its lowest value of $791.7 million during FY2024.
  • In the last 3 years, Fresenius Medical Care AG's Profit After Tax had a median value of $792.3 million in 2023 and averaged $842.2 million.
  • Per our database at Business Quant, Fresenius Medical Care AG's Profit After Tax increased by 1.76% in 2020 and then tumbled by 34.66% in 2022.
  • Fresenius Medical Care AG's Profit After Tax (MRY) stood at $1.6 billion in 2020, then fell by 12.00% to $1.4 billion in 2021, then tumbled by 34.66% to $942.6 million in 2022, then decreased by 15.94% to $792.3 million in 2023, then decreased by 0.08% to $791.7 million in 2024.
  • Its Profit After Tax was $791.7 million in FY2024, compared to $792.3 million in FY2023 and $942.6 million in FY2022.